Differences in innate immune signaling between alcoholic and non-alcoholic steatohepatitis

被引:28
|
作者
Petrasek, Jan [1 ]
Csak, Timea [1 ]
Ganz, Michal [1 ]
Szabo, Gyongyi [1 ]
机构
[1] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA
关键词
alcoholic liver disease; alcoholic steatohepatitis; inflammasome; innate immunity; interleukin-1; beta; interleukin-1 receptor antagonist; Kupffer cells; non-alcoholic steatohepatitis; Toll-like receptors; INDUCED LIVER-INJURY; IL-1 RECEPTOR ANTAGONIST; NECROSIS-FACTOR-ALPHA; TOLL-LIKE RECEPTOR-4; DIET-INDUCED OBESITY; RAT KUPFFER CELLS; FATTY LIVER; INTESTINAL PERMEABILITY; HEPATIC STEATOSIS; PLASMA ENDOTOXIN;
D O I
10.1111/jgh.12020
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The similar histopathological characteristics of alcoholic steatohepatitis (ASH) and nonalcoholic steatohepatitis (NASH), and the crucial role of the innate immune response in both conditions may lead to the assumption that ASH and NASH represent the same pathophysiological entities caused by different risk factors. In this review paper, we elaborate on the pathophysiological differences between these two entities and highlight the disease-specific involvement of signaling molecules downstream of the Toll-like receptor 4, and the differential mechanism by which the inflammasome contributes to ASH versus NASH. Our findings emphasize that ASH and NASH have disease-specific mechanisms and therefore represent distinct biological entities. Further studies are needed to dissect the emerging differences in pathogenesis of these two conditions.
引用
收藏
页码:93 / 98
页数:6
相关论文
共 50 条
  • [1] Alcoholic and non-alcoholic steatohepatitis
    Neuman, Manuela G.
    French, Samuel W.
    French, Barbara A.
    Seitz, Helmut K.
    Cohen, Lawrence B.
    Mueller, Sebastian
    Osna, Natalia A.
    Kharbanda, Kusum K.
    Seth, Devanshi
    Bautista, Abraham
    Thompson, Kyle J.
    McKillop, Iain H.
    Kirpich, Irina A.
    McClain, Craig J.
    Bataller, Ramon
    Nanau, Radu M.
    Voiculescu, Mihai
    Opris, Mihai
    Shen, Hong
    Tillman, Brittany
    Li, Jun
    Liu, Hui
    Thomes, Paul G.
    Ganesan, Murali
    Malnick, Steve
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2014, 97 (03) : 492 - 510
  • [2] Alcoholic and non-alcoholic steatohepatitis
    不详
    PATHOLOGY RESEARCH AND PRACTICE, 2005, 201 (03) : 266 - 266
  • [3] Progression of Alcoholic and Non-alcoholic Steatohepatitis: Common Metabolic Aspects of Innate Immune System and Oxidative Stress
    Sakaguchi, Shuhei
    Takahashi, Shougo
    Sasaki, Takamitsu
    Kumagai, Takeshi
    Nagata, Kiyoshi
    DRUG METABOLISM AND PHARMACOKINETICS, 2011, 26 (01) : 30 - 46
  • [4] Treatment of alcoholic and non-alcoholic steatohepatitis
    Stremmel, W
    Blechacz, B
    Herrmann, T
    Rost, D
    Mueller, S
    INTERNIST, 2001, 42 (12): : 1641 - +
  • [5] Combined alcoholic and non-alcoholic steatohepatitis
    Wandji, Line Carolle Ntandja
    Gnemmi, Viviane
    Mathurin, Philippe
    Louvet, Alexandre
    JHEP REPORTS, 2020, 2 (03)
  • [6] Interstrain differences in susceptibility to non-alcoholic steatohepatitis
    Yamazaki, Yuichi
    Kakizaki, Satoru
    Takizawa, Daichi
    Ichikawa, Takeshi
    Sato, Ken
    Takagi, Hitoshi
    Mori, Masatomo
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 (02) : 276 - 282
  • [7] INTERSTRAIN DIFFERENCES IN SUSCEPTIBILITY TO NON-ALCOHOLIC STEATOHEPATITIS
    Dorn, C.
    Hellerbrand, C.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S488 - S488
  • [8] Non-alcoholic Steatohepatitis (NASH) and alcoholic Steatohepatitis (ASH)
    Roeb, Elke
    DRUG RESEARCH, 2021, 71 : S16 - S18
  • [9] Alcoholic and non-alcoholic steatohepatitis: histological differences and pathogenesis of cytoskeleton alterations
    Denk, H
    Stumptner, C
    Zatloukal, K
    STEATOHEPATITIS (NASH AND ASH), 2001, 121 : 227 - 237
  • [10] Non-alcoholic steatohepatitis
    Dancygier, H
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2001, 126 (33) : 930 - 930